Search hospitals > Colorado > Aurora
Novartis Investigative Site
Claim this profileAurora, Colorado 80045
Global Leader in Multiple Sclerosis
Global Leader in Chronic Obstructive Pulmonary Disease
Conducts research for Heart Failure
Conducts research for Asthma
Conducts research for Cancer
309 reported clinical trials
6 medical researchers
Summary
Novartis Investigative Site is a medical facility located in Aurora, Colorado. This center is recognized for care of Multiple Sclerosis, Chronic Obstructive Pulmonary Disease, Heart Failure, Asthma, Cancer and other specialties. Novartis Investigative Site is involved with conducting 309 clinical trials across 220 conditions. There are 6 research doctors associated with this hospital, such as Marc Cornier, MD, Matthew M Heeney, Ranchhod Khant, and Karen Aspry.Top PIs
Marc Cornier, MDNovartis Investigative Site4 years of reported clinical research
Studies Cardiovascular Disease
Studies Feeding Disorders
3 reported clinical trials
5 drugs studied
Matthew M HeeneyChildrens Hospital Boston4 years of reported clinical research
Studies Sickle Cell Anemia
Studies Sickle Cell Disease
2 reported clinical trials
1 drug studied
Ranchhod KhantNovartis Investigative Site4 years of reported clinical research
Studies Cardiovascular Disease
1 reported clinical trial
1 drug studied
Karen AspryNovartis Investigative Site4 years of reported clinical research
Studies Cardiovascular Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Novartis Investigative Site
Multiple Sclerosis
Giant Cell Arteritis
Osteoarthritis
Spinal Muscular Atrophy
IgA Nephropathy
Polymyalgia Rheumatica
Cardiovascular Disease
Acute Myeloid Leukemia
Chronic Urticaria
Peanut Allergy
Ofatumumab
for Multiple Sclerosis
This trial will test if patients with a specific type of multiple sclerosis benefit from switching to a new medication. The medication aims to reduce harmful cells in the nervous system, potentially preventing future issues. It has been approved in several countries for treating this condition.
Recruiting3 awards Phase 410 criteria
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.
Recruiting2 awards Phase 3
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares remibrutinib and teriflunomide in patients with relapsing multiple sclerosis. It aims to find out which medication is more effective and safer. Both drugs work by controlling the immune system to reduce relapses. Teriflunomide is an approved treatment for adults with this condition.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Aurora, Colorado. This center is recognized for care of Multiple Sclerosis, Chronic Obstructive Pulmonary Disease, Heart Failure, Asthma, Cancer and other specialties. Novartis Investigative Site is involved with conducting 309 clinical trials across 220 conditions. There are 6 research doctors associated with this hospital, such as Marc Cornier, MD, Matthew M Heeney, Ranchhod Khant, and Karen Aspry.